TRN’s CEO, Andy McElroy, was in attendance at the ELF chemistry event in Belgium on the 6th-7th of November. He gave a well received lecture entitled “New Leads for Pain-related Targets via ELF Collaboration.”
The European Lead Factory (ELF) acknowledges the need for open exchange between researchers with different professional backgrounds and puts a focus on the career development of young scientists. Therefore, the European Lead Factory annually invites young talented EU Lead Factory chemists from participating small and medium-sized enterprises (SMEs) and academic institutions to a so-called Learnings and Achievements meeting, where they can present their scientific work, interact with colleagues and liaise with representatives from participating established pharmaceutical companies and SME partners.
The event continues to provide an excellent platform to share knowledge and reciprocal education, both between the consortium partners as well as within the larger scientific community. Many participants mentioned they also brought home new ideas. The conference delivered an excellent chance for participants to gain further insight into the whole drug discovery process as well as a great overview of the progress and work that has been carried out during the ELF project.
To find out more about the event, please visit: https://www.europeanleadfactory.eu/node/226